Vivos Inc. RDGL
Set alert
0.04 USD 0.00 -8.10%
As of Nov 2, 3:58 PM ET
0.0401 Day range 0.044
0.0391 52-week range 0.1244
- YTD
- -39.04%
- 1 year
- -45.45%
- Open
- 0.0438
- Prev close
- 0.0457
- Mkt cap
- 20.76M
- Vol
- 312.35K
- Avg vol
- 938.89K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0401
- High
- 0.044
YTD chart
Signals (49)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 12, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| MACD: Buy Signal | May 13, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 6 months ago |
| RSI: Oversold | May 1, 2026 | 6 months ago |
| RSI: Oversold | Apr 15, 2026 | 6 months ago |
| SMA: Bearish | Apr 10, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 26, 2026 | 7 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| SMA: Bullish | Mar 19, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 5, 2026 | 8 months ago |
| RSI: Overbought | Feb 24, 2026 | 8 months ago |
| RSI: Overbought | Feb 19, 2026 | 8 months ago |
| SMA: Bullish | Feb 10, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 9 months ago |
| SMA: Bullish | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Feb 3, 2026 | 9 months ago |
| MACD: Sell Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 27, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 27, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Mar 18, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 6, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 4, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
- Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders' Equity Standard
- Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
- Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test
- Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives
- Vivos Therapeutics Announces Material Debt Reduction
- Vivos Inc. Announces Peer-Reviewed Publication Characterizing PrecisionGel™ Polymer Platform in Elsevier Journal of Drug Delivery Science and Technology
- Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
- Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
- Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
- Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
Your note
Sign in to keep a note on RDGL — it syncs with the Stock Master app.